Rishi Shah

Rishi Shah is currently a final-year PhD student at the School of Pharmacy, University of Otago, New Zealand. His supervisors are Associate Professor Shyamal Das, Associate Professor Rajesh Katare and Associate Professor Greg Walker. He has completed his Bachelor of Pharmacy (2013) from Bharati Vidyapeeth Deemed University, Pune - India and his Master of Science in Pharmaceutical Technology (2014) from the University of Bradford, Bradford – United Kingdom.
His PhD work focuses on the pulmonary delivery of biological molecules incorporated into nanoparticles that can be used as a therapeutic approach for treating pulmonary diseases including chronic obstructive pulmonary disease (COPD). As a part of his PhD work, he has identified and evaluated the possible biomarker potential of the targeted biomolecules that are associated with pathological modifications of COPD. He is involved in the designing, preparation and optimization of nanoparticle formulation to encapsulate biomolecules and carry out in-vitro characterization studies. Rishi has also designed and optimized a method for spray-freeze drying technique for the production of microparticles for inhalation in “Das Laboratories”. His long-term objectives centre on biopharmaceutical inhalable nanoformulations, with a focus on powder formulations produced via spray-freeze drying.